Nanostics Announces Publication of a ClarityDX Prostate Study Validating New Algorithms with Improved Cancer Prediction that make MRI or DRE Optional - Elk Valley Times

July 12, 2026

Nanostics Announces Publication of a ClarityDX Prostate Study Validating New Algorithms with Improved Cancer Prediction that make MRI or DRE Optional

April 20, 2026

B EDMONTON, AB, April 20, 2026 /PRNewswire/ – Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX® platform, today announced the publication of…

posteditor

Articles: 16137

Accessibility Adjustments

Powered by OneTap

Select your accessibility profile

Vision Impaired Mode

Enhances website's visuals

Seizure Safe Profile

Clear flashes & reduces color

ADHD Friendly Mode

Focused browsing, distraction-free

Blindness Mode

Reduces distractions, improves focus

Epilepsy Safe Mode

Dims colors and stops blinking

Content Modules

Font Size

Default

Line Height

Default

Color Modules

Orientation Modules

Skip To Content